Article metrics

Download PDFPDF

Protocol
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol

 

Online download statistics by month:

Online download statistics by month: July 2021 to August 2022

AbstractFullPdf
Jul 2021472477130
Aug 2021291289198
Sep 2021147142107
Oct 202116214671
Nov 202116214977
Dec 202111911747
Jan 2022787239
Feb 2022666741
Mar 2022989450
Apr 2022787844
May 2022788155
Jun 2022575938
Jul 2022644928
Aug 2022131310
Total18851833935